Workshop Description/Objectives
Friday, November 12th
All times are Eastern Standard Time

9:00 AM - 12:15 PM 

LIVE TRACK 1:   F01. The History of Scientific Racism in Medicine and Prescriptions to Eradicate it, 3.0 CE

Presented by John Chenault, M.A.

This presentation examines the origins and deadly consequences of the unscientific theory of race-based medicine that permeates and structures every aspect of US medicine from clinical practice to biomedical research to medical education. It explains the government’s role in mandating the use of a racial classification system that has no basis in science yet perpetuates scientific racism through systemic mechanisms that resist efforts of reform and remediation. In closing, this talk offers a set of principles and guidelines for eliminating structural racism, health disparities, and social injustice in medicine. Skill Level: Beginning. 

Based on the content of this workshop, attendees will be able to:

  • Identify the origins of racialized “Blackness” and the “Black Body” as historical concepts socially constructed during colonialism and slavery.
  •  Recognize how and why the “Black Body” became central to the history of medicine and science in the United States.
  • Describe the role of physicians and biomedical researchers in the construction of race and the establishment of scientific racism.
  • Recognize how race and racial categories are constantly changing social concepts rather than immutable biological characteristics grounded in human evolution and genetics.
  • Recognize how the continued use of race-based and racialize medicine perpetuates health disparities and social inequities.
  • Explain how and why the use of racial categories persists in medicine and biomedical research despite the lack of scientific evidence for their support.



LIVE TRACK 2: F02. Introducing the MMPI-3, 3 CE

Presented by Dustin Wygant

In this program, attendees will be introduced to the MMPI-3. The presenter will review the rationale and development of the MMPI-3, focusing on how it built upon the MMPI-2 Restructured Form. This workshop will review each of the 52 scales on the MMPI-3 and the updated norms that were collected for the MMPI3. The workshop will cover the scoring and report options available on the MMPI-3. Finally, the presenter will cover the interpretation framework for the MMPI-3, which will be demonstrated in several case examples. Attendees will have the opportunity to ask questions and receive feedback. Skill level: Beginning

Based on the content of this workshop, attendees will be able to:

  • Understand the rational and process utilized in the development of the MMPI-3
  • Understand the updated norms on the MMPI-3 and how they impact the resulting test
  • Be familiar with all of the MMPI-3 scales
  • Understand and be able to implement the interpretative framework for the MMPI-3


12:30 PM - 1:30 PM 

KEYNOTE LUNCHEON:   F03. Achieving Health Equity: Psychology's Role, 1 CE 

Presented by Jennifer Kelly, Ph.D. 

 The US Centers for Disease Control defines health disparities as preventable differences in the burden of disease, injury, violence, or opportunities to achieve optimal health that are experienced by socially disadvantaged populations. Health disparities related to race are often the result of persistent unjust policies and discriminatory practices that increase the risk of Black, Indigenous, People of Color (BIPOC) populations for poor health. Health disparities have been observed across virtually all indicators of poor health (e.g., morbid obesity, cardiovascular disease, decreased life expectancy). Environmental, social and behavioral factors— all areas of psychology’s expertise— contribute to health disparities in interacting ways. Psychology must position itself as a force for achieving health equity by finding ways to make concrete improvements in the overall health of populations affected by disparities, and APA needs to support individual practitioners’ ability to do so in their own communities. This presentation will examine social determinants that contribute to health disparities, including, but not limited to, race, SES, gender, and geographical location. The unique contribution that psychological science and practice can offer in achieving health equity will be discussed. Skill Level: Beginning 

 Based on the content of this workshop, attendees will be able to:

  • Describe three examples of how current health practices contribute to health inequalities.
  • Identify three examples of how environmental and social factors systematically contribute to health inequalities. 
  • Articulate at least two ways in which psychological science and practice can help address health inequalities. 

 1:45- PM - 3:15 PM 

LIVE TRACK 1:   F04. Providing Culturally Sensitive Treatments to Address Mental Health Issues Among Children, 3.0 CE

 Presented by Erlanger Turner, Ph.D. 

 Over the course of the pandemic, research has shown increases in mental health difficulties among children. The focus of this session is to overview current trends in mental health among children from diverse backgrounds and identify principles of multicultural practice. Skill Level: Beginning. 

Based on the content of this workshop, attendees will be able to:

  • Understand current trends in mental health among children and their families from diverse groups.
  • Identify at least 3 guiding principles of multicultural practice.
  • Demonstrate an awareness of applying the multicultural guidelines when providing treatments to children.

LIVE TRACK 2:   F05. Evaluating Public Participation to Address Historic Racial Disenfranchisement and Empower Communities, 1.5 CE

 Presented by Daniel DeCaro, Ph.D., Allison S. Smith, Ph.D.

 This workshop will discuss methods for assessing perceptions of "participation" and "empowerment" during public engagement events in racially marginalized communities. This session will also provide recommendations for meaningful public engagement and inform how to improve the public participation process to better empower these communities. Skill Level: Intermediate. 

 Based on the content of this workshop, attendees will be able to: 

  • Critique and apply psychological assessments (surveys) of public engagement events to better evaluate the participatory fit and empowerment provided by those events
  • Learn principles and methods to tailor public engagement processes to stakeholders and issues, and identify important situational obstacles, as a critical component of best practices.
  • Recognize the historic barriers to community empowerment in racially and economically marginalized communities, as well as the importance of multi-stakeholder collaboration (government, non-government, and community stakeholders) to overcome these barriers.

3:30 PM - 5:00 PM


LIVE TRACK 1:   F04. Providing Culturally Sensitive Treatments to Address Mental Health Issues Among Children, 3.0 CE

Presented by Erlanger Turner, Ph.D. 

Click here for description/objectives



LIVE TRACK 2:   F06. Social and Peer Influences on Substance Use: Views from Preclinical to Practice, 1.5 CE

Presented by Michael Bardo, Ph.D., Heather Hodges, LCSW

This workshop is the first in what we hope to make a series of workshops bringing clinicians and researchers together to understand the full continuum of disorders. This workshop will focus on both pre-clinical and clinical understandings of substance use. This session will feature two presenters, Michael Bardo and Heather Hodges, who will present on social and peer influences in substance use. Dr. Bardo will present preclinical laboratory data while Ms. Hodges will present on the role of social and peer influences in clinical settings. Dr. Stoops will moderate the session.

Based on the content of this workshop, attendees will be able to:

  • Explain how a social peer can influence drug taking behavior.
  • Describe the concept of peer-induced relapse.
  • Translate how drug taking in rats is relevant to treating human substance use disorders.
  • Explain neurobiology of the reward pathway and the impact of peer approval.
  • Demonstrate evidence of the role of peer approval in initiation and continuation of substance abuse.
  • Describe the role of peer approval in a safe, recovery environment and the correlation of long-term sobriety.

 Return to Main Convention Page